Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10096-2 | ZM-447439 | LSM-1096 |  | 9914412 | |
| 10514-1 | PS-1145 |  | 9949093 | ||
| 10262-1 | L-779450 | LSM-4283 |  | 9950176 | |
| 10504-1 | Chk2 inhibitor II | BML-277 |  | 9969021 | |
| 10253-1 | Glycyl-H-1152 | LSM-4274 |  | ||
| 10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 |  | |
| 10279-1 | Trichostatin A | LSM-43005 |  |